NASDAQ: CYCN
Cyclerion Therapeutics Inc Stock Ownership - Who owns Cyclerion Therapeutics?

Insider buying vs selling

Have Cyclerion Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Rhonda M. ChickoCFO2026-08-1425,000$2.36
$58.88kBuy
Regina Margaret GraulCEO;Pres2026-08-1455,849$3.30
$184.30kBuy
Regina Margaret GraulCEO;Pres2026-08-1448,629$3.79
$184.30kSell

1 of 1

CYCN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CYCN insiders and whales buy or sell their stock.

CYCN Shareholders

What type of owners hold Cyclerion Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Peter M. Hecht19.45%910,336$3.71MInsider
Terrance McGuire16.47%771,191$3.14MInsider
Amy W. Schulman13.54%633,625$2.58MInsider
Andreas Busch5.44%254,704$1.04MInsider
Mark G. Currie5.38%251,648$1.02MInsider
Regina Margaret Graul2.30%107,523$437.62kInsider
William Huyett1.44%67,590$275.09kInsider
Christopher I. Wright0.91%42,728$173.90kInsider
Anjeza Gjino0.67%31,599$128.61kInsider
Michael J. 1. Higgins0.66%30,740$125.11kInsider

1 of 3

CYCN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CYCN0.07%68.96%Net BuyingNet Buying
LEXX0.10%49.45%
KTTA0.05%38.98%Net BuyingNet Buying
PLUR0.00%100.00%Net Buying
RKTO0.01%32.45%Net Selling

Cyclerion Therapeutics Stock Ownership FAQ

Who owns Cyclerion Therapeutics?

Cyclerion Therapeutics (NASDAQ: CYCN) is owned by 0.07% institutional shareholders, 68.96% Cyclerion Therapeutics insiders, and 30.97% retail investors. Peter M. Hecht is the largest individual Cyclerion Therapeutics shareholder, owning 910,336.00 shares representing 19.45% of the company. Peter M. Hecht's Cyclerion Therapeutics shares are currently valued at $3.54M.

If you're new to stock investing, here's how to buy Cyclerion Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.